Tech Company Financing Transactions
Cadence Neuroscience Funding Round
JAZZ Venture Partners, Epilepsy Foundation and Mayo Medical Ventures participated in a $15 million Series A funding round for Cadence Neuroscience. The round was announced by the company on 10/14/2019.
Transaction Overview
Company Name
Announced On
10/14/2019
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2036 223rd Pl. NE
Sammamish, WA 98074
USA
Sammamish, WA 98074
USA
Phone
Website
Email Address
Not Recorded
Overview
Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy. Our core technology has been developed at Mayo Clinic and is under clinical evaluation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kent Leyde
Chief Scientific Officer
Douglas Sheffield
Browse more venture capital transactions:
Prev: 10/14/2019: Florence Healthcare venture capital transaction
Next: 10/14/2019: Descartes Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs